Used as an intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals. Its structure supports the development of protease inhibitors and other drug candidates where metabolic stability and binding affinity are important. The trifluoro group enhances lipophilicity and resistance to oxidation, making it valuable in medicinal chemistry for improving pharmacokinetic properties. Also employed in the preparation of chiral building blocks for asymmetric synthesis.